Highbridge Capital Management »

Karyopharm Therapeutics shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Karyopharm Therapeutics shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 24M 0.75
2025-06-30 $18M 24M 0.75